vs
Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.
Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $40.7M, roughly 1.0× PETMED EXPRESS INC). Neuronetics, Inc. runs the higher net margin — -17.2% vs -26.0%, a 8.7% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -23.3%). Neuronetics, Inc. produced more free cash flow last quarter ($692.0K vs $-9.2M). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -20.9%).
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
PETS vs STIM — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $40.7M | $41.8M |
| Net Profit | $-10.6M | $-7.2M |
| Gross Margin | 23.3% | 52.0% |
| Operating Margin | -25.7% | -12.1% |
| Net Margin | -26.0% | -17.2% |
| Revenue YoY | -23.3% | 85.7% |
| Net Profit YoY | -1392.6% | 43.2% |
| EPS (diluted) | $-0.50 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $40.7M | $41.8M | ||
| Q3 25 | $44.4M | $37.3M | ||
| Q2 25 | $51.2M | $38.1M | ||
| Q1 25 | $50.8M | $32.0M | ||
| Q4 24 | $52.0M | $22.5M | ||
| Q3 24 | $58.0M | $18.5M | ||
| Q2 24 | $66.2M | $16.4M | ||
| Q1 24 | $65.1M | $17.4M |
| Q4 25 | $-10.6M | $-7.2M | ||
| Q3 25 | $-8.5M | $-9.0M | ||
| Q2 25 | $-34.2M | $-10.1M | ||
| Q1 25 | $-11.6M | $-12.7M | ||
| Q4 24 | $-707.0K | $-12.7M | ||
| Q3 24 | $2.3M | $-13.3M | ||
| Q2 24 | $3.8M | $-9.8M | ||
| Q1 24 | $-5.0M | $-7.9M |
| Q4 25 | 23.3% | 52.0% | ||
| Q3 25 | 28.0% | 45.9% | ||
| Q2 25 | 28.1% | 46.6% | ||
| Q1 25 | 29.9% | 49.2% | ||
| Q4 24 | 31.0% | 66.2% | ||
| Q3 24 | 32.3% | 75.6% | ||
| Q2 24 | 28.8% | 74.0% | ||
| Q1 24 | 29.3% | 75.1% |
| Q4 25 | -25.7% | -12.1% | ||
| Q3 25 | -18.9% | -19.6% | ||
| Q2 25 | -66.7% | -21.1% | ||
| Q1 25 | -11.9% | -34.4% | ||
| Q4 24 | -0.9% | -51.0% | ||
| Q3 24 | 1.0% | -41.7% | ||
| Q2 24 | 6.6% | -51.7% | ||
| Q1 24 | -5.9% | -39.4% |
| Q4 25 | -26.0% | -17.2% | ||
| Q3 25 | -19.2% | -24.3% | ||
| Q2 25 | -66.7% | -26.6% | ||
| Q1 25 | -22.9% | -39.6% | ||
| Q4 24 | -1.4% | -56.4% | ||
| Q3 24 | 4.0% | -72.0% | ||
| Q2 24 | 5.7% | -59.8% | ||
| Q1 24 | -7.7% | -45.2% |
| Q4 25 | $-0.50 | $-0.10 | ||
| Q3 25 | $-0.41 | $-0.13 | ||
| Q2 25 | $-1.65 | $-0.15 | ||
| Q1 25 | $-0.56 | $-0.21 | ||
| Q4 24 | $-0.03 | $-0.34 | ||
| Q3 24 | $0.11 | $-0.44 | ||
| Q2 24 | $0.18 | $-0.33 | ||
| Q1 24 | $-0.24 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.9M | $28.1M |
| Total DebtLower is stronger | — | $65.8M |
| Stockholders' EquityBook value | $32.8M | $22.4M |
| Total Assets | $88.0M | $141.6M |
| Debt / EquityLower = less leverage | — | 2.94× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.9M | $28.1M | ||
| Q3 25 | $36.1M | $28.0M | ||
| Q2 25 | $41.1M | $11.0M | ||
| Q1 25 | $54.7M | $20.2M | ||
| Q4 24 | $50.1M | $18.5M | ||
| Q3 24 | $52.0M | $20.9M | ||
| Q2 24 | $46.0M | $42.6M | ||
| Q1 24 | $55.3M | $47.7M |
| Q4 25 | — | $65.8M | ||
| Q3 25 | — | $65.7M | ||
| Q2 25 | — | $55.5M | ||
| Q1 25 | — | $55.3M | ||
| Q4 24 | — | $55.2M | ||
| Q3 24 | — | $46.0M | ||
| Q2 24 | — | $59.8M | ||
| Q1 24 | — | $59.4M |
| Q4 25 | $32.8M | $22.4M | ||
| Q3 25 | $43.1M | $27.4M | ||
| Q2 25 | $51.5M | $27.1M | ||
| Q1 25 | $85.1M | $35.5M | ||
| Q4 24 | $96.2M | $27.7M | ||
| Q3 24 | $96.4M | $9.4M | ||
| Q2 24 | $93.5M | $19.4M | ||
| Q1 24 | $96.7M | $27.7M |
| Q4 25 | $88.0M | $141.6M | ||
| Q3 25 | $100.3M | $145.5M | ||
| Q2 25 | $109.8M | $134.7M | ||
| Q1 25 | $148.7M | $142.0M | ||
| Q4 24 | $144.8M | $140.9M | ||
| Q3 24 | $146.0M | — | ||
| Q2 24 | $152.7M | $96.8M | ||
| Q1 24 | $169.9M | $103.8M |
| Q4 25 | — | 2.94× | ||
| Q3 25 | — | 2.40× | ||
| Q2 25 | — | 2.05× | ||
| Q1 25 | — | 1.56× | ||
| Q4 24 | — | 1.99× | ||
| Q3 24 | — | 4.90× | ||
| Q2 24 | — | 3.08× | ||
| Q1 24 | — | 2.15× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.2M | $908.0K |
| Free Cash FlowOCF − Capex | $-9.2M | $692.0K |
| FCF MarginFCF / Revenue | -22.7% | 1.7% |
| Capex IntensityCapex / Revenue | 0.1% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-23.0M | $-21.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.2M | $908.0K | ||
| Q3 25 | $-2.2M | $-785.0K | ||
| Q2 25 | $-12.3M | $-3.5M | ||
| Q1 25 | $7.0M | $-17.0M | ||
| Q4 24 | $-1.2M | $-8.6M | ||
| Q3 24 | $7.4M | $-5.4M | ||
| Q2 24 | $-8.5M | $-5.0M | ||
| Q1 24 | $7.1M | $-12.0M |
| Q4 25 | $-9.2M | $692.0K | ||
| Q3 25 | $-4.8M | $-899.0K | ||
| Q2 25 | $-13.6M | $-3.8M | ||
| Q1 25 | $4.6M | $-17.2M | ||
| Q4 24 | $-1.9M | $-8.7M | ||
| Q3 24 | $6.1M | $-5.8M | ||
| Q2 24 | $-9.2M | $-5.6M | ||
| Q1 24 | $5.9M | $-12.4M |
| Q4 25 | -22.7% | 1.7% | ||
| Q3 25 | -10.8% | -2.4% | ||
| Q2 25 | -26.5% | -9.9% | ||
| Q1 25 | 9.1% | -53.8% | ||
| Q4 24 | -3.7% | -38.6% | ||
| Q3 24 | 10.6% | -31.3% | ||
| Q2 24 | -13.9% | -34.0% | ||
| Q1 24 | 9.0% | -71.1% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 5.9% | 0.3% | ||
| Q2 25 | 2.5% | 0.7% | ||
| Q1 25 | 4.7% | 0.7% | ||
| Q4 24 | 1.5% | 0.4% | ||
| Q3 24 | 2.2% | 2.1% | ||
| Q2 24 | 1.0% | 3.7% | ||
| Q1 24 | 1.9% | 2.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.18× | — | ||
| Q2 24 | -2.27× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
STIM
Segment breakdown not available.
